This is a post about Australia’s largest milk processor Murray Goulburn which listed on the Australian stock exchange on July 3 at $2.10 – the lower end of its indicative range. The upper limit envisaged was $3.20. At this price… Read More ›
Company review
CSL – A Healthcare Gem
Chart Review This is a daily, twelve month, candlestick chart for Healthcare stock CSL Limited. Points to be made: In the latter half of last year the share price trended higher from around $65 until it lost momentum and entered into a… Read More ›
Admedus Revisited
Financial Results for 2015 I have followed this fledgling biotech company since February 2013, when the shares were trading at 2.2 cents a share following a 2 cent capital raising. Two and a half years later, after another three capital… Read More ›
PMP Limited continues its recovery. A company review.
Previous post reference; https://technicality.me/2013/04/24/chart-analysis-pmp-limited/ From December 2010 until January 2013 the share-price of print and marketing company PMP Limited fell in a steady down-trend from a high of $1.07 to a low of only 13 cents as the future of… Read More ›
CTN-Contango Microcap Fund. A review.
Contango Micro-Cap Fund was reviewed about eighteen months ago (08/12/2013) as a professionally managed fund with exceptional returns. Retail investors gain exposure to a difficult but potentially lucrative sector of the ASX. Technical features Over the past six months Contango… Read More ›
Where to for Sirtex’s share-price?
It may be that the share-price of Sirtex is entering a broad trading between $19 and $29 after the dramatic fall from grace on the 17th March 2015 to $14.80 from $40. There have been two higher highs since then… Read More ›
The SIRTEX Trial, Part 2
Why Sirtex needs a new direction In the ten years that Mr Gilman Wong has been CEO of Sirtex, he has steered the Healthcare company to incredible success to the delight of shareholders. The share-price recently touched a high of… Read More ›
The Sirflox trial – A perspective on the Study Abstract. Part 1.
Disclaimer With a medical background I have taken an interest in some stocks in the Biotech, and Health Care sectors. I do not now have a shareholding in Sirtex, but might in the future. I am mostly a long-only, medium-term… Read More ›
CBA Chart review
CBA has been in a strong uptrend since October last year. A record high of $96.60 was reached on the 23/3/2015 prior to the share-price entering into a triangular trading range, with the prices easing somewhat. In the last two… Read More ›
CHART REVIEW – UPDATE ON SIRTEX.
This blog reviewed the ASX listed stock Sirtex (SRX) on the 15/1/2014. https://technicality.me/2014/01/15/sirtex-succeeds/ At that time this stock was in full flight, propelled by strong momentum that appeared at that time to be starting to falter. A dramatic fall from… Read More ›
